Iovance Biotherapeutics Inc banner

Iovance Biotherapeutics Inc
NASDAQ:IOVA

Watchlist Manager
Iovance Biotherapeutics Inc Logo
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Watchlist
Price: 4.11 USD 11.08% Market Closed
Market Cap: $1.7B

Wall St Price Targets

IOVA Price Targets Summary
Iovance Biotherapeutics Inc

Wall Street analysts forecast IOVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IOVA is 8.61 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

Lowest Forecast
Price Target
4.04 USD
2% Downside
Average Forecast
Price Target
8.61 USD
110% Upside
Highest Forecast
Price Target
14.7 USD
258% Upside
Iovance Biotherapeutics Inc Competitors:
Price Targets
FAST
Fastenal Co
8% Upside
LGI
Lgi Ltd
31% Upside
EBMT
Eagle Bancorp Montana Inc
3% Upside
MRVL
Marvell Technology Group Ltd
-33% Downside
TCPC
BlackRock TCP Capital Corp
14% Upside

Revenue
Forecast

N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 18%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IOVA's stock price target?
Price Target
8.61 USD

According to Wall Street analysts, the average 1-year price target for IOVA is 8.61 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
18%

The compound annual growth rate for Revenue over the next 8 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett